Summary
We describe an enzyme immunoassay for the determination of complement-binding rheumatoid factors. Polystyrene tubes are coated with heat aggregated human IgG. The rheumatoid factors (RFs) of patients heat inactivated sera are allowed to bind to aggregated IgG and thereafter saturated with fresh human complement. The amount of C 3 complement bound is measured by indirect enzyme immunoassay. The levels of complement binding RFs were measured in 30 patients with seropositive rheumatoid arthritis (RA), in 19 patients with systemic lupus erythematosus (SLE), and in 30 healthy control subjects. Compared to the controls high levels of complement-binding RFs were found both in RA and in SLE (P<0.0005). The mean level of the complement binding RFs was higher (P<0.05) in active than in inactive SLE. Even though the 19 S IgM RF bound complement, in RA no correlation was found between the level of complement binding RFs and Waaler-Rose titre, but the level of complement binding RF correlated with the levels of nonagglutinating IgM RF (r=0.56, P<0.01) and IgG RF (r=0.70, P<0.001) that were obtained by enzyme immunoassay.
Similar content being viewed by others
References
Natvig JB, Winchester RJ (1969) Complement in rheumatoid inflammation. Acta Rheum Scand 15:161–166
Schur RH, Austin KF (1972) Complement in the rheumatic diseases. Bull Rheum Dis 22:666–670
Scott DGI, Bacon PA, Tribe CR (1981) Systemic rheumatoid vasculitis: a clinical and laboratory study of 50 cases. Clin Exp Immunol 43:81–92
Elson CJ, Scott DG, Blake DR, Bacon PA, Holt PD (1983) Complement-activating rheumatoid-factor-containing complexes in patients with rheumatoid vasculitis. Ann Rheum Dis 42:147–150
Conn DL, McDuffie FC, Dyck PJ (1972) Immunopathological study of sural nerves in rheumatoid arthritis. Arthritis Rheum 15:135–143
Conn DL, Schroeter AL, McDuffie FC (1976) Cutaneous vessel immune deposits in rheumatoid arthritis. Arthritis Rheum 19:15–21
Hunder GG, McDuffie FC (1973) Hypocomplementaemia in rheumatoid arthritis. Am J Med 54:461–465
Scott DGI, Bacon PA, Allen C, Elson CJ, Wallington T (1981) IgG rheumatoid factor, complement and immune complexes in rheumatoid synovitis and vasculitis: comparative and serial studies during cytotoxic therapy. Clin Exp Immunol 43:54–63
Allen C, Elson DJ, Scott DGI, Bacon PA, Bucknall R (1981) IgG antiglobulins in rheumatic diseases. Ann Rheum Dis 40:127–131
Pope RM, McDuffy SJ (1979) IgG rheumatoid factor: relationship to seropositive rheumatoid arthritis and absence in seronegative disorders. Arthritis Rheum 22:988–1002
Reyes PA, Maluf JG, Curd JG, Vaughan JH (1983) Association of rheumatoid factor with complement activation in rheumatoid arthritis and other diseases. Clin Exp Immunol 53:391–396
Moore TL, Zucker J, Baldassare AR, Weiss TD, Dorner RW (1978) Complement-fixing rheumatoid factor in juvenile rheumatoid arthritis. Arthritis Rheum 21:930–936
Robbins DL, Moore TL (1980) Lack of hidden complement fixing IgM in adult seronegative RA. Ann Rheum Dis 39:64–67
Tanimoto K, Cooper NR, Johnson JS (1975) Complement fixation by rheumatoid factor. J Clin Invest 55:437–445
Tesar JT, Schmid FR (1970) Conversion of soluble immune complexes into complement-fixing aggregates by IgM-rheumatoid factor. J Immunol 105:1206–1214
Zwaifler NJ, Bloch KJ (1962) Rheumatoid factor — an inhibitor of the complement-fixation reaction. Arthritis Rheum 5:127–133
March RE, Reebach JS, Holborow EJ, Jones VE, Jacoby RK (1982) The complement fixing properties and class distribution of rheumatoid factors (antiglobulins) in rheumatoid arthritis and other diseases. Clin Exp Immunol 48:555–560
Bolton WK, Schrock JH, Davis JS (1982) Rheumatoid factor inhibition of in vitro binding of IgG complexes in the human glomerulus. Arthritis Rheum 25:297–303
Sabharwal UK, Vaughan JH, Fong S, Bennett PH, Carson DA, Curd JG (1982) Activation of the classical pathway of complement by rheumatoid factors. Assessment by radioimmunoassay for C4. Arthritis Rheum 25:161–167
Jakle C, Feigal DW, Robins DL, Shapiro R, Wiesner K (1985) Serum IgG and IgM rheumatoid factors and complement activation in extraarticular rheumatoid disease. J Rheumatol 12:227–232
Bampton JLM, Cawston TE, Kyle MV, Hazleman BL (1985) Measurement of rheumatoid factors by an enzyme-linked immunosorbent assay (ELISA) and comparison with other methods. Ann Rheum Dis 44:13–19
Maury CPJ, Teppo A-M (1985) Rheumatoid factors and amyloidosis in rheumatoid arthritis. Br Med J 12:1015–1016
Wager O, Teppo A-M (1978) Binding affinity of human auto-antibodies: studies of cryoglobulin IgM rheumatoid factors and IgG autoantibodies to albumin. Scand J Immunol 7:503–509
Morrison M, Bayse GS, Webster RG (1971) Use of lactoperoxidase catalysed iodination in immunochemical studies. Immunochemistry 8:289–291
Teppo A-M (1981) Enzyme immunoassay of antibodies to Sjögren's syndrome B antigen. Clin Chem 27:1341–1345
Brown PB, Nardella FA, Mannik M (1982) Human complement activation by self-associated IgG rheumatoid factors. Arthritis Rheum 25:1101–1107
Schmid FR, Roitt IM, Rocha MJ (1970) Complement fixation by a two-component antibody system: immunoglobulin G and immunoglobulin M anti-globulin (rheumatoid factor). J Exp Med 132:673–683
Teppo A-M, Kurki P, Helve T, Wegelius O (1984) DNA-antibodies with and without complement binding ability. Rheumatol Int 4:173–176
Wager O, Lindström P (1982) Interference by rheumatoid factor and C1q with detection of IgG complexes. Studies on model systems by ELISA. Scand J Immunol 15:319–328
Abruzzo JL, Heimer R (1974) IgG anti-IgG antibodies in rheumatoid arthritis and certain other conditions. Ann Rheum Dis 33:258–262
Pope RM, McDuffy SJ (1981) IgG rheumatoid factor: analysis of various species of IgG for detection by radioimmunoassay. J Lab Clin Med 97:842–853
Ilter OD, Turner NW (1973) Determination of IgG antiglobulins in rheumatic disease using insolubilized human IgG. Clin Exp Immunol 15:93–99
Stankaitiene DJ, Matulis AA, Guobys H, Jusenaite JP (1978) Serum antiglobulins reactive with human and rabbit IgG in rheumatoid arthritis and other conditions. Arthritis Rheum 21:120–126
Burton DR, Boyd J, Brampton AD, Easterbrook-Smith SB, Emanuel EJ, Novotny J, Rademacher TW, van Schravendijk MR, Sternberg MJE, Dwek RA (1980) The C1q receptor site on immunoglobulin G. Nature 288:338–340
Hällgren R (1979) Human serum inhibits the interaction between C1q or rheumatoid factor and IgG-coated Latex particles. Reduction of these C1-dependent properties after complement activation in vitro and in vivo. Immunology 38:529–537
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Teppo, AM., Maury, C.P.J. Enzyme immunoassay of complement-binding rheumatoid factors. Rheumatol Int 6, 31–35 (1986). https://doi.org/10.1007/BF00270662
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00270662